Current regulatory approaches for accessing potential COVID-19 therapies

This commentary aims to elaborate challenges in the regulatory approaches for accessing and investigating COVID-19 potential therapies either with off-label use, compassionate use, emergency use or for clinical trials. Since no therapies have been formally approved and completely effective and safe...

Descripción completa

Detalles Bibliográficos
Autores principales: Halimi, Vesa, Daci, Armond, Stojanovska, Simona, Panovska-Stavridis, Irina, Stevanovic, Milena, Filipce, Venko, Grozdanova, Aleksandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229878/
https://www.ncbi.nlm.nih.gov/pubmed/32454981
http://dx.doi.org/10.1186/s40545-020-00222-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229878/
https://www.ncbi.nlm.nih.gov/pubmed/32454981
http://dx.doi.org/10.1186/s40545-020-00222-6

Ejemplares similares